dc.creatorDonati, KD
dc.creatorRabagliati, R
dc.creatorTumbarello, M
dc.creatorTacconelli, E
dc.creatorAmore, C
dc.creatorCauda, R
dc.creatorLacoviello, L
dc.date.accessioned2024-01-10T12:06:00Z
dc.date.accessioned2024-05-02T16:54:25Z
dc.date.available2024-01-10T12:06:00Z
dc.date.available2024-05-02T16:54:25Z
dc.date.created2024-01-10T12:06:00Z
dc.date.issued2003
dc.identifier10.1097/01.aids.0000050875.71999.ca
dc.identifier1473-5571
dc.identifier0269-9370
dc.identifierMEDLINE:12646805
dc.identifierhttps://doi.org/10.1097/01.aids.0000050875.71999.ca
dc.identifierhttps://repositorio.uc.cl/handle/11534/76100
dc.identifierWOS:000182566700020
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9267324
dc.description.abstractHigher levels of soluble adhesion molecules have been found before the introduction of highly active antiretroviral therapy (HAART) in HIV-positive compared with HIV-negative patients. To evaluate the impact of HAART on endothelial function we measured the plasmatic concentrations of soluble adhesion molecules in 120 HIV-positive patients. Concentrations of P-selectin and fibrinolytic factors were significantly higher in HAART patients, whereas soluble intercellular adhesion molecule-1 did not differ significantly. HAART may induce an activation of endothelial function both directly and indirectly through lipid alterations.
dc.languageen
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.rightsregistro bibliográfico
dc.subjectCELL-ADHESION MOLECULES
dc.subjectPLASMINOGEN-ACTIVATOR
dc.subjectRISK
dc.subjectINHIBITOR
dc.subjectSELECTIN
dc.subjectANTIGEN
dc.subjectPLASMA
dc.titleIncreased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy
dc.typeartículo


Este ítem pertenece a la siguiente institución